Literature DB >> 9161114

Factor analysis, causal indicators and quality of life.

P M Fayers1, D J Hand.   

Abstract

Exploratory factor analysis (EFA) remains one of the standard and most widely used methods for demonstrating construct validity of new instruments. However, the model for EFA makes assumptions which may not be applicable to all quality of life (QOL) instruments, and as a consequence the results from EFA may be misleading. In particular, EFA assumes that the underlying construct of QOL (and any postulated subscales or 'factors') may be regarded as being reflected by the items in those factors or subscales. QOL instruments, however, frequently contain items such as diseases, symptoms or treatment side effects, which are 'causal indicators'. These items may cause reduction in QOL for those patients experiencing them, but the reverse relationship need not apply: not all patients with a poor QOL need be experiencing the same set of symptoms. Thus a high level of a symptom item may imply that a patient's QOL is likely to be poor, but a poor level of QOL need not imply that the patient probably suffers from that symptom. This is the reverse of the common EFA model, in which it is implicitly assumed that changes in QOL and any subscales 'cause' or are likely to be reflected by corresponding changes in all their constituent items; thus the items in EFA are called 'effect indicators.' Furthermore, disease-related clusters of symptoms, or treatment-induced side-effects, may result in different studies finding different sets of items being highly correlated; for example, a study involving lung cancer patients receiving surgery and chemotherapy might find one set of highly correlated symptoms, whilst prostate cancer patients receiving hormone therapy would have a very different symptom correlation structure. Since EFA is based upon analyzing the correlation matrix and assuming all items to be effect indicators, it will extract factors representing consequences of the disease or treatment. These factors are likely to vary between different patient subgroups, according to the mode of treatment or the disease type and stage. Such factors contain little information about the relationship between the items and any underlying QOL constructs. Factor analysis is largely irrelevant as a method of scale validation for those QOL instruments that contain causal indicators, and should only be used with items which are effect indicators.

Entities:  

Mesh:

Year:  1997        PMID: 9161114     DOI: 10.1023/a:1026490117121

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  22 in total

Review 1.  Structural equation models in medical research.

Authors:  P M Bentler; J A Stein
Journal:  Stat Methods Med Res       Date:  1992       Impact factor: 3.021

2.  Measurement of quality of life in women with breast cancer. Development of a Life Satisfaction Questionnaire (LSQ-32) and a comparison with the EORTC QLQ-C30.

Authors:  M Carlsson; E Hamrin
Journal:  Qual Life Res       Date:  1996-04       Impact factor: 4.147

3.  Quality of life during chemotherapy for small cell lung cancer. I. An evaluation with generic health measures.

Authors:  B Bergman; M Sullivan; S Sörenson
Journal:  Acta Oncol       Date:  1991       Impact factor: 4.089

4.  The use of causal indicators in covariance structure models: some practical issues.

Authors:  R C MacCallum; M W Browne
Journal:  Psychol Bull       Date:  1993-11       Impact factor: 17.737

5.  Randomized trial assessing the addition of interferon alpha-2a to fluorouracil and leucovorin in advanced colorectal cancer. Colorectal Cancer Working Party of the United Kingdom Medical Research Council.

Authors:  M T Seymour; M L Slevin; D J Kerr; D Cunningham; R D James; J A Ledermann; T J Perren; W A McAdam; P G Harper; J P Neoptolemos; M Nicholson; A M Duffy; R J Stephens; S P Stenning; I Taylor
Journal:  J Clin Oncol       Date:  1996-08       Impact factor: 44.544

6.  The Diabetes Health Profile (DHP): a new instrument for assessing the psychosocial profile of insulin requiring patients--development and psychometric evaluation.

Authors:  K Meadows; N Steen; E McColl; M Eccles; C Shiels; J Hewison; A Hutchinson
Journal:  Qual Life Res       Date:  1996-04       Impact factor: 4.147

7.  A multi-center evaluation of the McGill Pain Questionnaire: results from more than 1700 chronic pain patients.

Authors:  Kenneth A Holroyd; Jeffrey E Holm; Francis J Keefe; Judith A Turner; Laurence A Bradley; William D Murphy; Patrick Johnson; Karen Anderson; Andrew L Hinkle; Brian W O'Malley
Journal:  Pain       Date:  1992-03       Impact factor: 6.961

8.  The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology.

Authors:  N K Aaronson; S Ahmedzai; B Bergman; M Bullinger; A Cull; N J Duez; A Filiberti; H Flechtner; S B Fleishman; J C de Haes
Journal:  J Natl Cancer Inst       Date:  1993-03-03       Impact factor: 13.506

9.  Screening for anxiety and depression in cancer patients: the effects of disease and treatment.

Authors:  T Ibbotson; P Maguire; P Selby; T Priestman; L Wallace
Journal:  Eur J Cancer       Date:  1994       Impact factor: 9.162

10.  Assessing quality of life in cancer patients.

Authors:  P Maguire; P Selby
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640

View more
  92 in total

Review 1.  Multidimensional scaling as a tool for analysing quality of life data.

Authors:  G Kemmler; B Holzner; M Kopp; M Dünser; R Greil; E Hahn; B Sperner-Unterweger
Journal:  Qual Life Res       Date:  2002-05       Impact factor: 4.147

2.  Primary care, self-rated health, and reductions in social disparities in health.

Authors:  Leiyu Shi; Barbara Starfield; Robert Politzer; Jerri Regan
Journal:  Health Serv Res       Date:  2002-06       Impact factor: 3.402

3.  Quality of life for adolescents: assessing measurement properties using structural equation modelling.

Authors:  Lynn B Meuleners; Andy H Lee; Colin W Binns; Anthony Lower
Journal:  Qual Life Res       Date:  2003-05       Impact factor: 4.147

4.  Quantitative assessment of changes in patients' constructs of quality of life: an application of multilevel models.

Authors:  Adam Lowy; Jürg Bernhard
Journal:  Qual Life Res       Date:  2004-09       Impact factor: 4.147

5.  Occurrences and sources of Differential Item Functioning (DIF) in patient-reported outcome measures: Description of DIF methods, and review of measures of depression, quality of life and general health.

Authors:  Jeanne A Teresi; Mildred Ramirez; Jin-Shei Lai; Stephanie Silver
Journal:  Psychol Sci Q       Date:  2008

6.  Missing data methods for dealing with missing items in quality of life questionnaires. A comparison by simulation of personal mean score, full information maximum likelihood, multiple imputation, and hot deck techniques applied to the SF-36 in the French 2003 decennial health survey.

Authors:  Hugo Peyre; Alain Leplège; Joël Coste
Journal:  Qual Life Res       Date:  2010-10-01       Impact factor: 4.147

7.  The Menopause-Specific Quality of Life Questionnaire: psychometric evaluation among breast cancer survivors.

Authors:  Jill V Radtke; Lauren Terhorst; Susan M Cohen
Journal:  Menopause       Date:  2011-03       Impact factor: 2.953

8.  PedsQL™ Cognitive Functioning Scale in pediatric liver transplant recipients: feasibility, reliability, and validity.

Authors:  James W Varni; Christine A Limbers; Lisa G Sorensen; Katie Neighbors; Karen Martz; John C Bucuvalas; Estella M Alonso
Journal:  Qual Life Res       Date:  2010-12-24       Impact factor: 4.147

9.  Psychometric assessment of health-related quality of life and symptom experience in HIV patients treated with antiretroviral therapy.

Authors:  Christophe Lalanne; Andrew R Armstrong; Susan Herrmann; Sophie Le Coeur; Patrizia Carrieri; Olivier Chassany; Martin Duracinsky
Journal:  Qual Life Res       Date:  2014-12-07       Impact factor: 4.147

10.  A shortened version of the Western ontario rotator cuff disability index: development and measurement properties.

Authors:  Helen Razmjou; Paul Stratford; Richard Holtby
Journal:  Physiother Can       Date:  2012-04-05       Impact factor: 1.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.